Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Extracellular vesicle-derived bioactive molecules for corneal and ocular surface regeneration
Avtorji:ID Kolenc, Ana (Avtor)
ID Dimnik, Živa (Avtor)
ID Marzidovšek, Miha (Avtor)
ID Schollmayer, Petra (Avtor)
ID Hawlina, Marko (Avtor)
ID Maličev, Elvira (Avtor)
ID Lužnik Marzidovšek, Zala (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,39 MB)
MD5: 8723327DBA61684AE26FA8A5002A434D
 
URL URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2077-0383/14/15/5594
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Cell-based therapies emerge as potential treatment options for various debilitating diseases. Preclinical research and clinical studies involving cells increased exponentially in the past decade. In addition to cell-based approaches, the use of extracellular vesicles (EVs), which are released by nearly all cell types, emerged as a promising cell-free alternative. Those approaches are also being explored in the field of ophthalmology. Several clinical trials involving EVs are underway to develop potential treatments for advanced ocular surface diseases, including corneal disorders, injuries, and dry eye disease. The cargo carried by EVs has been shown to include a diverse array of functional molecules such as transcription factors, cytokines, growth factors, mRNA, tRNA, rRNA, miRNA, and fragments of dsDNA. While the molecular composition of EVs is already well characterised, the specific activity of these molecules upon delivery to recipient cells remains poorly understood. In this review, we summarise recent studies investigating the bioactive molecules within EVs shown to influence or modulate cellular activity on the ocular surface. Among these, various miRNAs have most commonly been identified as therapeutic agents targeting distinct molecular pathways. The EVs studied were predominantly derived from various mesenchymal stem cells.
Ključne besede:extracellular vesicles, bioactive molecules, cornea, dry eye disease, miRNA, mesenchymal stem cells, ophthalmology
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 1-17
Številčenje:Vol. 14, iss. 15, [article no.] 5594
PID:20.500.12556/DiRROS-24274 Novo okno
UDK:617.7
ISSN pri članku:2077-0383
DOI:10.3390/jcm14155594 Novo okno
COBISS.SI-ID:245312259 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 11. 8. 2025;
Datum objave v DiRROS:24.11.2025
Število ogledov:133
Število prenosov:67
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Journal of clinical medicine
Skrajšan naslov:J. clin. med.
Založnik:MDPI
ISSN:2077-0383
COBISS.SI-ID:5405759 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J3-50107-2023
Naslov:Učinkovitost mezenhimskih matičnih celic (MMC) in zunajceličnih veziklov, pridobljenih iz MMC, za obnovo roženičnega tkiva

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj